Anoro Ellipta 30 inhalations, containing Umeclidinium bromide and Vilanterol triphenyl acetate, are manufactured by GlaxoSmithKline. This medication is approved for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD). It is available as 30 inhalations per 1 kit, with YJ code 2259806G2028.
Anoro Ellipta 30 inhalations
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →